Noopept
August 1, 2023Incremental
4/10
Purrptide digest
Noopept is technically a peptide-derived nootropic, dosed in milligrams rather than the grams typical of racetams like Piracetam — meaning it's vastly more potent by weight. It's approved in Russia as a prescription cognitive enhancer for memory impairment, with mechanisms involving both AMPA receptor modulation and NGF/BDNF upregulation. The nootropics community outside Russia adopted it widely, treating it as an accessible entry point into peptide-adjacent cognitive enhancement.
What this means for you
🏃
If you care about weight/health
One of the more accessible cognitive peptides — widely available and dosed in small, manageable amounts compared to older racetams.
🩺
If you're a clinician
Approved in Russia for memory impairment with a dual mechanism (AMPA modulation plus neurotrophin upregulation) that's reasonably well characterized.
🔬
If you're a researcher
The combination of fast-acting AMPA receptor effects with slower neurotrophin-mediated effects gives it an interesting dual-timescale mechanism.
💸
If you follow biotech
A well-established nootropics-market product. Not a frontier biotech bet, but a stable consumer category performer.
OS
Ostrovskaya et al.
Russian Academy of Medical Sciences
For the nerds
Nootropic and neuroprotective effects of GVS-111 (Noopept)
Bulletin of Experimental Biology and Medicine · DOI: 10.1023/A:1019829709139
Read full paper on PubMed →